A detailed history of Deka Bank Deutsche Girozentrale transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 93,807 shares of IONS stock, worth $2.95 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
93,807
Previous 93,807 -0.0%
Holding current value
$2.95 Million
Previous $4.42 Million 14.0%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$42.03 - $53.55 $92,171 - $117,435
2,193 Added 2.39%
93,807 $4.16 Million
Q3 2023

Nov 13, 2023

BUY
$38.5 - $47.13 $62,139 - $76,067
1,614 Added 1.79%
91,614 $4.24 Million
Q2 2023

Jul 25, 2023

SELL
$34.73 - $43.33 $2.6 Million - $3.25 Million
-75,000 Reduced 45.45%
90,000 $3.71 Million
Q1 2023

Apr 24, 2023

BUY
$33.58 - $41.2 $402,960 - $494,400
12,000 Added 7.84%
165,000 $5.72 Million
Q4 2022

Feb 01, 2023

BUY
$37.12 - $46.52 $1.05 Million - $1.31 Million
28,224 Added 22.62%
153,000 $5.7 Million
Q1 2022

Apr 28, 2022

BUY
$29.88 - $37.04 $457,164 - $566,712
15,300 Added 13.98%
124,776 $4.45 Million
Q4 2021

Feb 02, 2022

BUY
$25.61 - $35.1 $48,659 - $66,690
1,900 Added 1.77%
109,476 $3.35 Million
Q2 2021

Aug 05, 2021

SELL
$34.54 - $47.25 $339,148 - $463,947
-9,819 Reduced 8.36%
107,576 $4.27 Million
Q1 2021

Apr 28, 2021

BUY
$42.51 - $63.78 $52,924 - $79,406
1,245 Added 1.07%
117,395 $5.24 Million
Q4 2020

Mar 12, 2021

BUY
$45.3 - $60.27 $298,708 - $397,420
6,594 Added 6.02%
116,150 $6.63 Million
Q3 2020

Oct 29, 2020

BUY
$47.45 - $62.95 $4.82 Million - $6.39 Million
101,478 Added 1256.23%
109,556 $5.25 Million
Q2 2020

Aug 04, 2020

BUY
$46.85 - $61.05 $8,386 - $10,927
179 Added 2.27%
8,078 $476,000
Q1 2020

May 14, 2020

SELL
$41.6 - $63.4 $12,105 - $18,449
-291 Reduced 3.55%
7,899 $376,000
Q4 2019

Feb 04, 2020

BUY
$53.85 - $65.27 $441,031 - $534,561
8,190 New
8,190 $489,000
Q3 2019

Nov 14, 2019

SELL
$59.06 - $72.15 $4.89 Million - $5.97 Million
-82,781 Closed
0 $0
Q2 2019

Aug 01, 2019

SELL
$62.09 - $86.14 $3.42 Million - $4.75 Million
-55,095 Reduced 39.96%
82,781 $5.38 Million
Q1 2019

May 10, 2019

BUY
$52.92 - $81.17 $3.56 Million - $5.45 Million
67,200 Added 95.08%
137,876 $6.4 Million
Q4 2018

Feb 12, 2019

SELL
$43.37 - $59.54 $2.91 Million - $4 Million
-67,200 Reduced 48.74%
70,676 $3.75 Million
Q3 2018

Nov 09, 2018

BUY
$42.88 - $53.7 $5.17 Million - $6.48 Million
120,600 Added 698.08%
137,876 $0
Q2 2018

Aug 14, 2018

SELL
$40.53 - $50.7 $1.22 Million - $1.52 Million
-30,000 Reduced 63.46%
17,276 $725,000
Q1 2018

May 03, 2018

SELL
$44.08 - $55.05 $264,480 - $330,300
-6,000 Reduced 11.26%
47,276 $2.17 Million
Q3 2017

Nov 06, 2017

BUY
$45.56 - $59.57 $2.43 Million - $3.17 Million
53,276
53,276 $2.53 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.46B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.